Clinical Trial: Phase 1b Clinical Study in Patients With Active Ulcerative Colitis

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07834515) titled 'Phase 1b Clinical Study in Patients With Active Ulcerative Colitis' on July 20.

Brief Summary: Purpose of study is to evaluate the safety, tolerability, pharmacokinetics of TP317 vs. placebo in adults with active ulcerative colitis. Participants will be randomly assigned to receive either daily oral tablets (8 tablets) of TP317 (80 mg) or an identical placebo pill. Study will include 2 colonoscopies, daily dosing (including at home and in clinic), safety assessments, diary and questionnaire completion and 5 in clinic visits.

Study Start Date: Sept. 16

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: ...